The Peptide NewsroomPeptide research, industry and supply-chain headlines

Martha Stewart's Elm Launches a $45 Peptide Lip Serum, But Its Study Is a Perception Test

Topic card: skin-beauty

Elm Biosciences, the skincare company co-founded by Martha Stewart and board-certified dermatologist Dr. Dhaval Bhanusali, is launching Elemental Lip Serum on September 22 at $45, in four shades: Blush, Petal, Mocha, and Clear.

The product is described as a balm-oil hybrid built around peptides, antioxidants, shea butter, squalane, and what the brand calls a deep hydration complex. Peptides are short chains of amino acids used in cosmetic formulas as conditioning and signaling ingredients, and their inclusion here is the reason a lip balm lands on a peptide news desk rather than a beauty column.

The pitch is lip care as skin care

Elm's argument is that lips are one of the most overlooked parts of a beauty routine and deserve the same treatment logic as facial skin. That framing is doing real work commercially: it moves a tinted balm out of the makeup aisle, where $45 is a hard sell, and into treatment, where it is unremarkable.

The serum is positioned to address visible signs of lip aging while delivering hydration, comfort, and a sheer tint. In other words, wearable color with treatment claims attached, which is the most crowded corner of the category right now.

What the study actually was

Elm Biosciences points to a dermatologist-supervised perception study involving 54 women who used the product for seven days. A perception study asks users what they noticed, which is a different kind of evidence from an instrumented measure of hydration or lip texture, and seven days is a short window for anything described as long-term care.

No outcome figure from that study appears in the coverage, and the brand's own framing concedes that individual results can vary. For a formula sold on visible signs of lip aging, the absence of a published result is the most informative detail available.

The dermatologist network

The company says its product development is informed by a network of more than 350 dermatologists, scientists, and researchers. That is a credentialing claim, not a data claim, and the two get conflated often enough in this category to be worth separating.

Bottom line

What Elm has launched is a peptide-containing tinted lip treatment at $45 with a seven-day user-perception study behind it. Whether the formula does anything measurable to lip skin over months rather than a week is a question nobody has published an answer to yet.

Source: RSS.app — Peptides bundle. Read the original.

Filed under: skin-beauty

Comments (0)

Discussion happens on Reddit.
Questions and corrections go to r/PeptideNewsroom.

Go to r/PeptideNewsroom

Corrections are the most useful thing you can post. Comments touching dosing, sourcing or links are held for a moderator first.

More from The Peptide Newsroom

Doctors Prescribe GLP-1 Drugs to Some Children, But Physician Calls Them a Tool Not a Cure

An Aging Untold segment reports that GLP-1 weight-loss drugs are being prescribed to some children, with physician Rhea Rogers describing them as a tool rather than a miracle drug. Experts cited say candidates have a BMI at or above the 95th percentile after lifestyle changes have failed, though the segment carries no trial data.

IndexBox Forecasts 5.8% Annual Growth for Collagen Tablets, But Claims Rules Could Tighten

IndexBox projects the global collagen peptides tablets market growing at 5.8% annually through 2035, reaching a market index of 168 against a 2025 baseline. The report flags regulatory tightening on health claims and collagen supply concentration as the two main risks to that trajectory.

California Clinic Pitches a Hollywood Peptide Stack, But Says It Is Not Validated

A press release from California Trim Clinic promotes an article on NAD+, copper peptides and a tirzepatide-based Hollywood Glow Stack. Its own disclaimers say the combination is not FDA-approved or clinically validated.